Perficient Inc (PRFT) 20.01 $PRFT Perficient Reports

New Post Public Reply Private Reply Replies (0) Message Board

Sep 1, 2016 at 3:03 PM

Perficient Inc (PRFT) 20.01 $PRFT

Perficient Reports Second Quarter 2016 Results
BusinessWire - Thu Aug 04, 7:00AM CDT
Perficient, Inc. (NASDAQ: PRFT) ("Perficient"

, the leading digital transformation consulting firm serving Global 2000(R) and other large enterprise customers throughout North America, today reported its financial results for the quarter ended June 30, 2016.
PRFT: 20.01 (+0.04)

25.7% Return Seen to Date on SmarTrend Perficient Call (PRFT)
Comtex SmarTrend(R) - Wed Aug 03, 1:01PM CDT
SmarTrend identified an Uptrend for Perficient (NASDAQ

RFT) on November 27th, 2015 at $17.52. In approximately 8 months, Perficient has returned 25.68% as of today's recent price of $22.02.
PRFT: 20.01 (+0.04)

The Henry Ford Receives Award for Its Work with Perficient Digital
BusinessWire - Thu Jun 23, 11:37AM CDT
Perficient, Inc. (NASDAQ: PRFT) ("Perficient"

, the leading digital transformation consulting firm serving Global 2000(R) and other large enterprise customers throughout North America, today announced that the work of its digital agency, Perficient Digital, in redesigning The Henry Ford website, has been recognized with a Silver MUSE Award through the American Alliance of Museums.
PRFT: 20.01 (+0.04)

Zacks.com featured highlights: Banc of California, Cirrus Logic, LKQ, Newell Brands and Perficient
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 8:30AM CDT
Zacks.com featured highlights: Banc of California, Cirrus Logic, LKQ, Newell Brands and Perficient
NWL: 53.16 (+0.08), LKQ: 35.65 (-0.44), BANC: 22.26 (-0.06), CRUS: 51.87 (+1.12), PRFT: 20.01 (+0.04)

What's Your Stock's Price Target?
Kevin Matras - ZACKS - Tue Jun 21, 1:59PM CDT
What's Your Stock's Price Target?
NWL: 53.16 (+0.08), LKQ: 35.65 (-0.44), BANC: 22.26 (-0.06), CRUS: 51.87 (+1.12), PRFT: 20.01 (+0.04)

Uptrend Call Working As Perficient Stock Rises 22.5% (PRFT)
Comtex SmarTrend(R) - Tue Jun 07, 12:49AM CDT
SmarTrend identified an Uptrend for Perficient (NASDAQ

RFT) on November 27th, 2015 at $17.52. In approximately 6 months, Perficient has returned 22.55% as of today's recent price of $21.47.
PRFT: 20.01 (+0.04)

Perficient posts 1Q profit
Automated Insights - Thu May 05, 7:22AM CDT
ST. LOUIS (AP) _ Perficient Inc. (PRFT) on Thursday reported first-quarter earnings of $5.4 million.
PRFT: 20.01 (+0.04)

Perficient Reports First Quarter 2016 Results
BusinessWire - Thu May 05, 7:00AM CDT
Perficient, Inc. (NASDAQ: PRFT) ("Perficient"

, the leading digital transformation consulting firm serving Global 2000(R) and other large enterprise customers throughout North America, today reported its financial results for the quarter ended March 31, 2016.
PRFT: 20.01 (+0.04)

Perficient Launches 'Cloud First, Business-Driven' Initiative with Webinar on May 5
BusinessWire - Wed Apr 27, 8:27AM CDT
Perficient, Inc. (NASDAQ: PRFT) ("Perficient"

, the leading digital transformation consulting firm serving Global 2000(R) and other large enterprise customers throughout North America, today announced it will launch the company's "Cloud First, Business-Driven" initiative with the first in a series of thought leadership-focused webinars on the topic at 1 p.m. Central time on May 5.
PRFT: 20.01 (+0.04)

4 Small-Cap Growth Stocks to Invest In
Zacks Equity Research - Zacks Investment Research - Tue Apr 19, 9:29AM CDT
For investors with high risk appetite and return expectations, small cap growth stocks are the best bet given the current low volatile market environment.
FOR: 12.41 (-0.14), ROCK: 38.42 (+0.26), CHUY: 30.08 (-0.20), PRFT: 20.01 (+0.04), BHI: 49.24 (+0.11)

Perficient Announces the Launch of Its Digital Agency, Perficient Digital
BusinessWire - Mon Apr 18, 10:07AM CDT
Perficient, Inc. (NASDAQ: PRFT) ("Perficient"

, the leading digital transformation consulting firm serving Global 2000(R) and other large enterprise customers throughout North America, today announced the launch of Perficient Digital, a full-service digital agency focused on improving customer experiences - the defining strategic imperative in the marketplace for companies today.
PRFT: 20.01 (+0.04)

Perficient Announces Partnership with St. Louis Cardinals
BusinessWire - Fri Apr 08, 8:01AM CDT
Perficient, Inc. (NASDAQ: PRFT) ("Perficient"

, the leading digital transformation consulting firm serving Global 2000(R) and other large enterprise customers throughout North America, today announced it has entered into a multi-year partnership with the St. Louis Cardinals.
PRFT: 20.01 (+0.04)

Diamond Sponsor Perficient to Present on Magento 2.0 Optimization at Imagine 2016
BusinessWire - Thu Apr 07, 3:06PM CDT
Perficient, Inc. (NASDAQ: PRFT) ("Perficient"

, the leading digital transformation consulting firm serving Global 2000(R) and other large enterprise customers throughout North America, today announced it will have thought leaders discussing the new Magento 2.0, an open source e-commerce platform, during Magento Imagine 2016.
PRFT: 20.01 (+0.04)

Perficient to Speak on Life Sciences Cloud Implementations at Oracle Industry Connect
BusinessWire - Tue Apr 05, 8:29AM CDT
Perficient, Inc. (NASDAQ: PRFT) ("Perficient"

, the leading digital transformation consulting firm serving Global 2000(R) and other large enterprise customers throughout North America, today announced that one of its thought leaders will speak about Siebel Clinical cloud implementations for life sciences organizations during Oracle Industry Connect 2016, April 11-13 in Orlando, Fla.
PRFT: 20.01 (+0.04)

Perficient to Present on Oracle Cloud-Based Solutions at Collaborate 16
BusinessWire - Fri Apr 01, 8:11AM CDT
Perficient, Inc. (NASDAQ: PRFT) ("Perficient"

, the leading digital transformation consulting firm serving Global 2000(R) and other large enterprise customers throughout North America, today announced it will have Oracle technology experts leading discussions on cloud-based solutions during Collaborate 16 in Las Vegas.
PRFT: 20.01 (+0.04)

Perficient to Announce First Quarter 2016 Results on May 5
BusinessWire - Wed Mar 30, 8:03AM CDT
Perficient, Inc. (NASDAQ: PRFT) ("Perficient"

, the leading digital transformation consulting firm serving Global 2000(R) and other large enterprise customers throughout North America, today announced it will host a conference call on Thursday, May 5, at 10 a.m. Eastern time, to discuss the company's first quarter 2016 results.
PRFT: 20.01 (+0.04)

CACI International Shows Potential for Long-Term Growth
Zacks Equity Research - Zacks Investment Research - Mon Mar 28, 2:05PM CDT
On Mar 28, Zacks Investment Research updated the research report on information technology services provider, CACI International Inc. (CACI).
CACI: 98.79 (-0.57), EBIX: 57.61 (+0.61), PRFT: 20.01 (+0.04), KEYW: 9.84 (-0.13)

Perficient to Announce Fourth Quarter and Full-Year 2015 Results on March 3
BusinessWire - Fri Feb 05, 8:07AM CST
Perficient, Inc. (NASDAQ: PRFT) ("Perficient"

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

CVS Study: GLP-1 Drugs Effective But Costly

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...